Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nerea Allende-Vega

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Scientific Reports|April 6, 2019
Metabolic stress controls mutant p53 R248Q stability in acute myeloid leukemia cellsNerea Allende-Vega, Martin Villalba
Seminars in Cancer Biology|November 10, 2009
Targeting the ubiquitin-proteasome system to activate wild-type p53 for cancer therapyNerea Allende-Vega, Mark K Saville
Molecular and Cellular Biochemistry|June 13, 2008
Transcription factor TAFII250 phosphorylates the acidic domain of Mdm2 through recruitment of protein kinase CK2Nerea Allende-Vega, Lynsey McKenzie, David Meek
Molecular and Cellular Biochemistry|December 13, 2005
Phosphorylation of the acidic domain of Mdm2 by protein kinase CK2Nerea Allende-Vega, Sylvia Dias, Diane Milne, et al.
Vaccines|December 5, 2020
Dissecting the NK Cell Population in Hematological Cancers Confirms the Presence of Tumor Cells and Their Impact on NK Population FunctionDang-Nghiem Vo, Michael Constantinides, Nerea Allende-Vega, et al.
The Journal of Biological Chemistry|December 23, 2008
Suppression of the deubiquitinating enzyme USP5 causes the accumulation of unanchored polyubiquitin and the activation of p53Saurabh Dayal, Alison Sparks, Jimmy Jacob, et al.
The International Journal of Biochemistry & Cell Biology|May 10, 2012
From tumor cell metabolism to tumor immune escapeMartin Villalba, Moeez G Rathore, Nuria Lopez-Royuela, et al.
The EMBO Journal|February 10, 2007
The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2Lauren F Stevenson, Alison Sparks, Nerea Allende-Vega, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 19, 2013
Chemical metabolic inhibitors for the treatment of blood-borne cancersMartin Villalba, Nuria Lopez-Royuela, Ewelina Krzywinska, et al.
Oncoimmunology|April 11, 2018
NK cell activation and recovery of NK cell subsets in lymphoma patients after obinutuzumab and lenalidomide treatmentDang-Nghiem Vo, Catherine Alexia, Nerea Allende-Vega, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Scientific Reports|April 6, 2019
Metabolic stress controls mutant p53 R248Q stability in acute myeloid leukemia cellsNerea Allende-Vega, Martin Villalba
Seminars in Cancer Biology|November 10, 2009
Targeting the ubiquitin-proteasome system to activate wild-type p53 for cancer therapyNerea Allende-Vega, Mark K Saville
Molecular and Cellular Biochemistry|June 13, 2008
Transcription factor TAFII250 phosphorylates the acidic domain of Mdm2 through recruitment of protein kinase CK2Nerea Allende-Vega, Lynsey McKenzie, David Meek
Molecular and Cellular Biochemistry|December 13, 2005
Phosphorylation of the acidic domain of Mdm2 by protein kinase CK2Nerea Allende-Vega, Sylvia Dias, Diane Milne, et al.
Vaccines|December 5, 2020
Dissecting the NK Cell Population in Hematological Cancers Confirms the Presence of Tumor Cells and Their Impact on NK Population FunctionDang-Nghiem Vo, Michael Constantinides, Nerea Allende-Vega, et al.
The Journal of Biological Chemistry|December 23, 2008
Suppression of the deubiquitinating enzyme USP5 causes the accumulation of unanchored polyubiquitin and the activation of p53Saurabh Dayal, Alison Sparks, Jimmy Jacob, et al.
The International Journal of Biochemistry & Cell Biology|May 10, 2012
From tumor cell metabolism to tumor immune escapeMartin Villalba, Moeez G Rathore, Nuria Lopez-Royuela, et al.
The EMBO Journal|February 10, 2007
The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2Lauren F Stevenson, Alison Sparks, Nerea Allende-Vega, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 19, 2013
Chemical metabolic inhibitors for the treatment of blood-borne cancersMartin Villalba, Nuria Lopez-Royuela, Ewelina Krzywinska, et al.
Oncoimmunology|April 11, 2018
NK cell activation and recovery of NK cell subsets in lymphoma patients after obinutuzumab and lenalidomide treatmentDang-Nghiem Vo, Catherine Alexia, Nerea Allende-Vega, et al.
Pageof 3